CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | Polsky Bruce Director | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | ||
| 2025-06-20 | Polsky Bruce Director | Option exercise · Restricted Stock Units | −29,600 | 0 | ||
| 2025-06-20 | Lucidi Bruno Director | Option exercise | +29,600 | 112,750 | ||
| 2025-06-20 | Lucidi Bruno Director | Grant or award · Restricted Stock Units | +29,600 | 29,600 | ||
| 2025-06-20 | Lucidi Bruno Director | Grant or award · Stock Option (Right to Buy) | +41,200 | 41,200 | ||
| 2025-06-20 | Lucidi Bruno Director | Option exercise · Restricted Stock Units | −29,600 | 0 | ||
| 2025-06-20 | Berman Howard Director | Grant or award · Stock Option (Right to Buy) | +164,800 | 164,800 | ||
| 2025-05-18 | Murphy Polly A. Director | Purchase | +6,100 | $4.17 | $25K | 92,145 |
| 2025-02-20 | Kirsch Arthur S Director | Grant or award · Stock Option (Right to Buy) | +164,800 | 164,800 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Option exercise | +46,800 | 84,272 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award | +11,250 | 95,522 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Shares withheld for taxes | −14,134 | $3.06 | $43K | 81,388 |
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Option exercise · Restricted Stock Units | −46,800 | 46,800 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Restricted Stock Units | +11,250 | 11,250 | ||
| 2025-01-31 | Hammond Janet MJ Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-01-31 | Vavricka John Chief Commercial Officer | Option exercise | +33,333 | 54,848 | ||
| 2025-01-31 | Vavricka John Chief Commercial Officer | Grant or award | +8,750 | 63,598 | ||
| 2025-01-31 | Vavricka John Chief Commercial Officer | Shares withheld for taxes | −11,517 | $3.06 | $35K | 52,081 |
| 2025-01-31 | Vavricka John Chief Commercial Officer | Option exercise · Restricted Stock Units | −33,333 | 33,333 | ||
| 2025-01-31 | Vavricka John Chief Commercial Officer | Grant or award · Restricted Stock Units | +8,750 | 8,750 |
Page 5 of 14 · 280 trades